99 Cent Urinalysis App Raises Questions About mHealth Standards
This article was originally published in The Gray Sheet
The uChek urinalysis app made a splash last month with its launch in the iTunes App Store, but it did not appear to follow the same pre-market requirements as analogous conventional urine analyzers, contributing to questions about mobile health regulatory oversight and innovation.
You may also be interested in...
The last five years have been brutal ones for medical device VCs and entrepreneurs, yet there’s still cause for hope. In a series of interviews, we asked venture capitalists, entrepreneurs, and executives: what gives you hope and what makes you optimistic about the future of medtech?
Federal officials took pains at this year’s mHealth Summit in Washington, D.C., to describe their excitement for the digital health field and their plans to minimize the “touch” of federal regulation. But it was also clear at the meeting that a significant component of the health information technology space still looks skeptically at FDA and its long-term intentions.
HHS Office of the National Coordinator for Health IT director departs. FDA accepts new interoperability standards. Verizon Health gains clearance for data device. Meta-analysis finds mixed results for self-monitoring blood pressure. Biosense pursues CE mark funding for uChek. Nanoengineers create sweat-monitoring tattoo.